Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 7, 2022
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
Sun, March 6, 2022
[ Sun, Mar 06th 2022
] - WOPRAI
Fri, March 4, 2022
[ Fri, Mar 04th 2022
] - WOPRAI
[ Fri, Mar 04th 2022
] - WOPRAI
[ Fri, Mar 04th 2022
] - WOPRAI
[ Fri, Mar 04th 2022
] - WOPRAI
[ Fri, Mar 04th 2022
] - WOPRAI
Rick Wise Maintained (TMCI) at Strong Buy with Decreased Target to $32 on, Mar 4th, 2022
Rick Wise of Stifel, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Decreased Target from $37 to $32 on, Mar 4th, 2022.
Rick has made no other calls on TMCI in the last 4 months.
There is 1 other peer that has a rating on TMCI. Out of the 1 peers that are also analyzing TMCI, 0 agree with Rick's Rating of Hold.
This is the rating of the analyst that currently disagrees with Rick
- Danielle Antalffy of "SVB Leerink" Maintained at Buy with Decreased Target to $32 on, Friday, November 5th, 2021
